Trials / Terminated
TerminatedNCT01144221
Bone Marrow Derived Mononuclear Cells for Ischemic Cardiomyopathy
Protocol on an Evaluative Study on Bone Marrow Derived Mononuclear Cells for Optimization of Biventricular Pacing in Patients With Chronic Ischemic Left Ventricular Dysfunction
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Kai Jaquet, PhD, DSc · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is an evaluative, monocentric study in patients with chronic ischemic heart disease and left bundle branch block who received an ICD-CRT. It is an early investigation on the safety and effects of a single administration of bone marrow derived mononuclear cells after implantation of an ICD-CRT device as an adjunct to CRT and usual drug treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Intramyocardial Cell therapy | Intramyocardial Cell therapy in patients with chronic ischemic heart disease after ICD CRT Implantation |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2013-05-01
- Completion
- 2015-02-01
- First posted
- 2010-06-15
- Last updated
- 2018-04-09
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01144221. Inclusion in this directory is not an endorsement.